Zide Chen

500 total citations
20 papers, 382 citations indexed

About

Zide Chen is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Zide Chen has authored 20 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cancer Research and 5 papers in Biomedical Engineering. Recurrent topics in Zide Chen's work include Nanoplatforms for cancer theranostics (5 papers), MicroRNA in disease regulation (3 papers) and Magnolia and Illicium research (2 papers). Zide Chen is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), MicroRNA in disease regulation (3 papers) and Magnolia and Illicium research (2 papers). Zide Chen collaborates with scholars based in China, Sweden and Macao. Zide Chen's co-authors include Jian Chen, Xiaofei Huang, Zhengzhi Wu, Cheng Tao, Zihuang Li, Jie‐Hua Chen, Xiaoyong Zhang, Min Ma, Xinping Li and Qiang Zeng and has published in prestigious journals such as Chemical Engineering Journal, Neuroscience and Small.

In The Last Decade

Zide Chen

18 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zide Chen China 13 191 90 75 74 50 20 382
Lixia Zheng China 13 208 1.1× 81 0.9× 49 0.7× 54 0.7× 45 0.9× 30 451
Liuyi Lu China 8 143 0.7× 86 1.0× 42 0.6× 74 1.0× 38 0.8× 16 376
Dong Wu China 13 230 1.2× 86 1.0× 70 0.9× 97 1.3× 41 0.8× 22 472
Qinsong Zeng China 13 166 0.9× 108 1.2× 71 0.9× 55 0.7× 22 0.4× 23 414
Karthikeyan Subburayan United Arab Emirates 9 170 0.9× 73 0.8× 37 0.5× 105 1.4× 26 0.5× 10 317
Jiaming Guo China 14 182 1.0× 79 0.9× 87 1.2× 93 1.3× 80 1.6× 29 506
Romina Rajabi Iran 8 171 0.9× 91 1.0× 54 0.7× 43 0.6× 25 0.5× 9 307
Tsung-Yao Lin Taiwan 7 221 1.2× 66 0.7× 70 0.9× 39 0.5× 39 0.8× 8 452
Jiafeng Gao China 15 250 1.3× 101 1.1× 79 1.1× 62 0.8× 70 1.4× 22 472

Countries citing papers authored by Zide Chen

Since Specialization
Citations

This map shows the geographic impact of Zide Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zide Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zide Chen more than expected).

Fields of papers citing papers by Zide Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zide Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zide Chen. The network helps show where Zide Chen may publish in the future.

Co-authorship network of co-authors of Zide Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zide Chen. A scholar is included among the top collaborators of Zide Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zide Chen. Zide Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Zide, Dongyang Wei, Qi Wang, et al.. (2024). Multifunctional biomimetic nanosystem for retinoblastoma treatment. Chemical Engineering Journal. 499. 156017–156017. 1 indexed citations
2.
Ye, Peng, et al.. (2023). Ephrin-A4 Ligand (EFNA4) Predicts Poor Prognosis of Hepatocellular Carcinoma and Promotes Tumor Proliferation. Journal of Clinical and Experimental Hepatology. 13(5). 767–773.
3.
Duo, Yanhong, Zide Chen, Zihuang Li, et al.. (2023). Combination of bacterial-targeted delivery of gold-based AIEgen radiosensitizer for fluorescence-image-guided enhanced radio-immunotherapy against advanced cancer. Bioactive Materials. 30. 200–213. 22 indexed citations
4.
5.
Chen, Zide, Qi Wang, Feng Shi, et al.. (2022). CircPOLR2A Promotes Proliferation and Impedes Apoptosis of Glioblastoma Multiforme Cells by Up-regulating POU3F2 to Facilitate SOX9 Transcription. Neuroscience. 503. 118–130. 3 indexed citations
6.
Liu, Chunping, Guiling Chen, Yanfen Chen, et al.. (2021). Danlou Tablets Inhibit Atherosclerosis in Apolipoprotein E-Deficient Mice by Inducing Macrophage Autophagy: The Role of the PI3K-Akt-mTOR Pathway. Frontiers in Pharmacology. 12. 724670–724670. 16 indexed citations
7.
Liu, Chunping, Zide Chen, Dongyue He, et al.. (2021). Therapeutic Applications of Functional Nanomaterials for Prostatitis. Frontiers in Pharmacology. 12. 685465–685465. 13 indexed citations
8.
Duo, Yanhong, Guanghong Luo, Zihuang Li, et al.. (2021). Photothermal and Enhanced Photocatalytic Therapies Conduce to Synergistic Anticancer Phototherapy with Biodegradable Titanium Diselenide Nanosheets. Small. 17(40). e2103239–e2103239. 27 indexed citations
9.
Huang, Xiaoting, Leyang Xiang, Wei Liu, et al.. (2021). Roles of diencephalon/mesencephalon homeobox 1 in the development and prognosis of hepatocellular carcinoma. Annals of Hepatology. 24. 100314–100314.
10.
Chen, Zide, Gang Xu, Dong Wu, et al.. (2020). Lobaplatin induces pyroptosis through regulating cIAP1/2, Ripoptosome and ROS in nasopharyngeal carcinoma. Biochemical Pharmacology. 177. 114023–114023. 41 indexed citations
11.
Tao, Cheng, Jian Chen, Xiaofei Huang, et al.. (2020). CT1-3, a novel magnolol-sulforaphane hybrid suppresses tumorigenesis through inducing mitochondria-mediated apoptosis and inhibiting epithelial mesenchymal transition. European Journal of Medicinal Chemistry. 199. 112441–112441. 17 indexed citations
12.
Chen, Jian, Xiaofei Huang, Cheng Tao, et al.. (2020). Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo. Cancer Chemotherapy and Pharmacology. 86(1). 151–161. 33 indexed citations
13.
Chen, Jian, Cheng Tao, Xiaofei Huang, et al.. (2020). CT2-3, a novel magnolol analogue suppresses NSCLC cells through triggering cell cycle arrest and apoptosis. Bioorganic & Medicinal Chemistry. 28(6). 115352–115352. 11 indexed citations
14.
Chen, Chengcong, et al.. (2020). Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC). Aging. 12(24). 25395–25411. 9 indexed citations
15.
Chen, Jian, Rongjun Zhang, Cheng Tao, et al.. (2020). CuS–NiS2 nanomaterials for MRI guided phototherapy of gastric carcinoma via triggering mitochondria-mediated apoptosis and MLKL/CAPG-mediated necroptosis. Nanotoxicology. 14(6). 774–787. 43 indexed citations
16.
Chen, Zide, Jie‐Hua Chen, Xuan Huang, et al.. (2019). Identification of Potential Key Genes for Hepatitis B Virus-Associated Hepatocellular Carcinoma by Bioinformatics Analysis. Journal of Computational Biology. 26(5). 485–494. 15 indexed citations
17.
Chen, Zide, et al.. (2019). MicroRNA‐450b‐3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma. Journal of Cellular Biochemistry. 120(11). 18805–18815. 37 indexed citations
18.
Chen, Zide, Jie‐Hua Chen, Hongyan Liu, et al.. (2018). The SMAC Mimetic APG-1387 Sensitizes Immune-Mediated Cell Apoptosis in Hepatocellular Carcinoma. Frontiers in Pharmacology. 9. 1298–1298. 31 indexed citations
19.
Ge, Junwei, Jie‐Hua Chen, Zide Chen, et al.. (2017). Lower Expression of MicroRNA-155 Contributes to Dysfunction of Natural Killer Cells in Patients with Chronic Hepatitis B. Frontiers in Immunology. 8. 1173–1173. 24 indexed citations
20.
Shi, Feng, et al.. (2017). Microwave ablation versus radiofrequency ablation for the treatment of pulmonary tumors. Oncotarget. 8(65). 109791–109798. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lixia Zheng Breakdown of academic impact, for papers by Liuyi Lu Breakdown of academic impact, for papers by Dong Wu Breakdown of academic impact, for papers by Qinsong Zeng Breakdown of academic impact, for papers by Karthikeyan Subburayan Breakdown of academic impact, for papers by Jiaming Guo Breakdown of academic impact, for papers by Romina Rajabi Breakdown of academic impact, for papers by Tsung-Yao Lin Breakdown of academic impact, for papers by Jiafeng Gao
Rankless by CCL
2026